Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist

被引:90
|
作者
Shepherd, J [1 ]
Little, MC [1 ]
Nicklin, MJH [1 ]
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield, S Yorkshire, England
关键词
chronic disease; mice; knockout; inflammation; interleukin; 1;
D O I
10.1111/j.0022-202X.2004.22305.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Interleukin-1 receptor antagonist-deficient (II1rn-/-) BALB/c mice developed inflammation localized to the skin of the ear pinna in 64% of the cases examined. Histopathologically, the disease had many features resembling human psoriasis, suggesting that it might be a useful disease model. The epidermis became thickened and hypertrophic, and expressed the immature keratin, K6, throughout. The stratum corneum showed parakeratotsis. Large epidermal projections formed into a grossly thickened dermis and both tissues were infiltrated by leukocytes. Neutrophil-rich microabscesses formed beneath the stratum corneum. Dendritic cells and activated T cells of both helper classes were identified in both the dermis and epidermis, while a high density of macrophages was seen in the dermis, where mast cells were also prominent. Dense patterns of apparently activated small dermal vessels were seen in the diseased dermis. Cutaneous inflammation, along with arterial inflammation and arthritis, is the third site-specific, inflammatory disease to be found to affect II1rn-/- BALB/c mice. None of the diseases affected II1rn-/- C57BL/6. In F2 hybrids of II1rn-/- BALB/c and C57BL/6, cutaneous inflammation was absent, aortic inflammation was common, and arthritis was rare, indicating that the sets of background modifier genes that cause susceptibility to each disease are not fully overlapping.
引用
收藏
页码:665 / 669
页数:5
相关论文
共 50 条
  • [1] Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1
    Milora, Katelynn A.
    Fu, Hangfei
    Dubaz, Ornella
    Jensen, Liselotte E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (12) : 2992 - 3000
  • [2] Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
    Nicklin, MJH
    Hughes, DE
    Barton, JL
    Ure, JM
    Duff, GW
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02): : 303 - 311
  • [3] INTRACELLULAR INTERLEUKIN-1 RECEPTOR ANTAGONIST RELEASED UPON CELL DEATH ACTS AS AN ALARMIN INHIBITOR IN ALDARA CREAM-INDUCED PSORIASIS-LIKE SKIN INFLAMMATION
    Martin, P.
    Palmer, G.
    Rodriguez, E.
    Palomo, J.
    Gabay, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : A42 - A43
  • [4] The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1
    Dinarello, CA
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10): : 732 - 734
  • [5] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
  • [6] INHIBITION BY INTERLEUKIN-1 RECEPTOR ANTAGONIST OF INVIVO ACTIVITIES OF INTERLEUKIN-1 IN MICE
    MENGOZZI, M
    BERTINI, R
    SIRONI, M
    GHEZZI, P
    LYMPHOKINE AND CYTOKINE RESEARCH, 1991, 10 (05): : 405 - 407
  • [7] INTERLEUKIN-1 RECEPTOR ANTAGONIST AND GENETIC SUSCEPTIBILITY TO INFLAMMATION
    DUFF, GW
    JOURNAL OF INTERFERON RESEARCH, 1994, 14 (05): : 305 - 305
  • [8] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [9] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [10] A PPARδ-selective antagonist ameliorates IMQ-induced psoriasis-like inflammation in mice
    Wang, Xuguo
    Hao, Yangyang
    Wang, Xiaohuan
    Wang, Lumei
    Chen, Yongchun
    Sun, Jun
    Hu, Jinhong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 40 : 73 - 78